Trading Signals: REGN Stock Price Prediction and Forecast (Fri. Mar. 14, 2014 - Fri. Dec. 22, 2023)(Regeneron Pharmaceuticals Inc)
| REGN latest price $583.2800 (1.74%) ($583.2800 - $583.2800) on Fri. Jul. 2, 2021. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 1.38% (three month average) | RSI | 76 | Latest Price | $583.2800(1.74%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | REGN advances 1.1% a day on average for past five trading days. | Weekly Trend | REGN advances 2.9% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support REGN advance at 0% a week (0% probability) IBB(52%) XLV(42%) DIA(37%) IWD(36%) SPLV(36%) | Factors Impacting REGN price | REGN will decline at least -0.69% in a week (0% probabilities). VIXM(-21%) UUP(-6%) TBT(-6%) VXX(-5%) IGOV(-1%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -0.69% (StdDev 1.38%) | Hourly BBV | 1.2 () | Intraday Trend | 0% | | | |
|
5 Day Moving Average | $560.73(4.02%) | 10 Day Moving Average | $550.63(5.93%) | 20 Day Moving Average | $538.61(8.29%) | To recent high | 0% | To recent low | 22.8% | Market Cap | $61.844b | | | | Regeneron Pharmaceuticals, Inc. is a biotechnology company, which engages in the discovery, invention, development, manufacture, and commercialization of medicines. It product portfolio includes the following brands: EYLEA, Dupixent, Praluent, Kevzara, Libtayo, ARCALYST, and ZALTRAP. The company was founded by Alferd G. Gilman, Leonard S. Schleifer, and Eric M. Shooter on January 8, 1988 and is headquartered in Tarrytown, NY. |